Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe entities : Novo nordisk a::S save search
Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results
Published: 2023-03-16 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.07%
H: 1.96%
C: 0.56%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.4%
H: 0.03%
C: -0.08%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -6.11%
H: 3.54%
C: 0.69%
pharma conference year financial
Innate Pharma Provides Update on Silicon Valley Bank Exposure
Published: 2023-03-13 (Crawled : 09:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.02%
H: 1.44%
C: -0.51%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.21%
H: 4.65%
C: -1.66%
pharma update
Number of Shares and Voting Rights of Innate Pharma as of December 1, 2022
Published: 2022-12-09 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.97%
H: 0.41%
C: -1.07%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 3.41%
H: 2.83%
C: 0.0%
pharma
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
Published: 2022-06-22 (Crawled : 11:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
partnership nash
Novo Holdings Portfolio Company F2G enters strategic collaboration with Shionogi to commercialise its new antifungal agent Olorofim in Europe and Asia
Published: 2022-05-16 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -2.14%
H: 1.02%
C: 0.02%
europe collaboration
Innate Pharma Files Its 2021 Universal Registration Document (Document d’enregistrement universel) and 2021 Annual Report on Form 20-F
Published: 2022-04-05 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.57%
H: 1.02%
C: 0.31%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.64%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: -3.43%
pharma report
Innate Pharma: First Patient Dosed in IPH6101/SAR443579 Phase 1/2 Clinical Trial in Various Blood Cancers
Published: 2021-12-16 (Crawled : 09:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -5.02%
H: 5.6%
C: 0.96%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 2.6%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -1.27%
H: 1.68%
C: 0.5%
iph6101 blood trial phase 1 cancer phase 2
Ozempic® 2.0 mg recommended for approval for the treatment of type 2 diabetes by the European Medicines Agency
Published: 2021-11-12 (Crawled : 11:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
diabetes treatment europe approval
Wegovy™ recommended for approval for the treatment of obesity by the European regulatory authorities
Published: 2021-11-11 (Crawled : 17:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
treatment obesity europe approval
BioSpace Movers & Shakers, Sept. 24
Published: 2021-09-24 (Crawled : 15:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.31%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
space spac
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.